jubilant generics ltd Jubilant Generics gets DCGI nod to manufacture COVID-19 drug Remdesivir On June 21, Hetero and Cipla and on July 2 Mylan were given permission to manufacture and market the drug on the same conditions « Previous1Next » 1 of 1